Dr. Datto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Concord Pike
Wilmington, DE 19850Phone+1 302-885-1948
Education & Training
- Rutgers Robert Wood Johnson Medical SchoolClass of 1994
Certifications & Licensure
- PA State Medical License 1996 - 2014
Clinical Trials
- Phase 3 /Seroquel SR Acute Mania Monotherapy - US Start of enrollment: 2007 Jan 01
- Phase III/Seroquel SR Bipolar Depression Monotherapy - US Start of enrollment: 2006 Dec 01
- Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsThe pilot study of a telephone disease management program for depression.Catherine J. Datto, Richard Thompson, David A. Horowitz, Maureen Disbot, David W. Oslin
General Hospital Psychiatry. 2003-05-01 - 74 citationsOlder patients' aversion to antidepressants. A qualitative study.Jane L. Givens, Catherine J. Datto, Katy Ruckdeschel, Kathryn Knott, Cynthia Zubritsky
Journal of General Internal Medicine. 2006-02-01 - 43 citationsSide effects of electroconvulsive therapy.Catherine J. Datto
Depression and Anxiety. 2000-01-01
Journal Articles
- Analysis of Patient–Provider Interactions Regarding the Burden and Treatment of Opioid-Induced Constipation in Adults with Chronic Noncancer PainCatherine Datto, MD, Pain Medicine
Press Mentions
- Opioid Utilization Patterns Among Patients with Cancer and Non-Cancer PainMarch 12th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: